Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations
- 1 March 2006
- journal article
- Published by Wiley in Transplant Infectious Disease
- Vol. 8 (1) , 21-30
Abstract
The most common organ‐specific manifestation of cytomegalovirus (CMV) infection after liver transplantation is hepatitis. Here we retrospectively describe the detailed virological, histological, immunological, and clinical findings associated with CMV infection in 229 consecutive adult liver transplantation patients. CMV infection was diagnosed by pp65 antigenemia. From 439 liver biopsies, CMV antigens were demonstrated by immunohistochemistry and CMV DNA by hybridization. The Banff criteria were used for histology. The expression of various adhesion molecules (intercellular adhesion molecule‐1 [ICAM‐1], vascular cell adhesion molecule‐1 [VCAM‐1], endothelial leukocyte adhesion molecule‐1 [ELAM‐1]), their ligands (leukocyte function antigen‐1 [LFA‐1], very late antigen‐4 [VLA‐4], Sialyl‐LewisX‐molecule [SLeX]), and lymphoid activation markers (major histocompatibility complex [MHC] Class II, interleukin‐2‐receptor [IL‐2R]) was demonstrated by immunohistochemistry.CMV infection of the transplant occurred in 26 patients (11% of all 229 patients and 17% of the 151 patients with liver biopsy). The incidence was higher among seronegative (26%) than in seropositive recipients (9%), but most cases 18/26 (70%) were reactivations. The CMV pp65 antigenemia levels were usually high in primary infections (893±1069, range 50–3000 pp65+cells), but varied widely in reactivations (388±740, range 3–3000). The histological Banff score was slightly increased (2.3±0.9). Microabscesses, lymphocytic infiltration, Kupffer cell reaction, and parenchymal alterations were common but viral inclusions rare. CMV significantly (P<0.05) increased ICAM‐1 and VCAM‐1 expression and the number of LFA‐1, VLA‐4, and Class II‐positive lymphocytes in the graft. All CMV infections were successfully treated with antivirals. Intragraft CMV infection had no influence on the long‐term outcome, but biliary complications were common.In conclusion, CMV infection of the liver transplant occurred both in primary infection and in reactivation, and also in the cases with low pp65 antigenemia levels. Microabscesses and other histological alterations were common but viral inclusions rare. Increased adhesion molecule expression was associated with lymphocyte infiltration. Successfully treated CMV hepatitis had no influence on the long‐term clinical outcome.Keywords
This publication has 20 references indexed in Scilit:
- CMV hepatitis after liver transplantation: Incidence, clinical course, and long-term follow-upLiver Transplantation, 2002
- The Significance of Microabscesses in Liver Transplant Biopsies: A Clinicopathological StudyHepatology, 1998
- Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allograftsHepatology, 1998
- Mini-microabscess syndrome in liver transplant recipientsHepatology, 1997
- Persistent cytomegalovirus in liver allografts with chronic rejectionHepatology, 1997
- Increased expression of adhesion molecules in liver allografts during cytomegalovirus infectionTransplant Immunology, 1996
- Histological diagnosis of cytomegalovirus hepatitis in liver allografts.Journal of Clinical Pathology, 1995
- Clinical Use of Immunohistopathologic Methods for the Diagnosis of Cytomegalovirus Hepatitis in Human Liver Allograft Biopsy SpecimensScandinavian Journal of Gastroenterology, 1994
- Intercellular immune adhesion molecules in human liver transplants: Overview on expression patterns of leukocyte receptor and ligand moleculesHepatology, 1993
- Cytomegalovirus Infection Persists in the Liver Graft in the Vanishing Bile Duct SyndromeHepatology, 1992